Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal Polyps

Article Link: Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal Polyps

South San Francisco, CA — December 1, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License…

Source: FDA New Drug Approvals